Chris Herold is a scientifically-trained entrepreneur. He received his undergraduate degree in Chemical Engineering at the University of Virginia, after which he spent nine months in Lausanne, Switzerland, at Scitec SA working on a Perkin Elmer Q-Mass quadrupole to analyze soil and water samples for toxic components. He returned to the US and completed his doctorate in Molecular Pathology at the University of California, San Diego (UCSD) and then joined the start-up, Prediction Sciences (PS). While at PS he wrote and directed SBIR grants from the NIH and NSF as Principal Investigator with the goal of identifying correlations between SNP profiles and drug response (pharmacogenomics). He left PS to complete an MBA at Cornell University, and then joined the start-up, Arrayomics, which focused on the development of liquid microarray technology. He is a founding board member of MSACL and, as President & COO, has been responsible for its operational logistics since the organization's inception.